Infect Immun 56(5): 1232-1236
Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages.
Abstract
The principal efferent role of the macrophage in acquired resistance to intracellular pathogens depends on activation by T-cell lymphokines, primarily gamma interferon (IFN-gamma). However, mouse macrophages that are heavily burdened with Mycobacterium leprae are refractory to activation by IFN-gamma and are thus severely compromised in their capacity for both enhanced microbicidal and tumoricidal activities. We report here that lipoarabinomannan (LAM), a highly immunogenic lipopolysaccharide that is a prominent component of the cell walls of M. leprae and M. tuberculosis, was a potent inhibitor of IFN-gamma-mediated activation of mouse macrophages in vitro. Inhibition of macrophage activation by LAM required preincubation for approximately 24 h, resulting in uptake of LAM into cytoplasmic vacuoles of macrophages. Intact LAM was necessary to inhibit IFN-gamma-mediated activation, as this property was lost when the acyl side chains were removed from LAM by mild alkaline hydrolysis. In addition, LAM was an abundant constituent of macrophages isolated from lepromatous granulomas of M. leprae-infected nude mice and likely contributed to the defective activation of granuloma macrophages by IFN-gamma.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Images in this article
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brennan PJ. The phthiocerol-containing surface lipids of Mycobacterium leprae--a perspective of past and present work. Int J Lepr Other Mycobact Dis. 1983 Sep;51(3):387–396. [PubMed] [Google Scholar]
- Celada A, Allen R, Esparza I, Gray PW, Schreiber RD. Demonstration and partial characterization of the interferon-gamma receptor on human mononuclear phagocytes. J Clin Invest. 1985 Dec;76(6):2196–2205.[PMC free article] [PubMed] [Google Scholar]
- Celada A, Schreiber RD. Internalization and degradation of receptor-bound interferon-gamma by murine macrophages. Demonstration of receptor recycling. J Immunol. 1987 Jul 1;139(1):147–153. [PubMed] [Google Scholar]
- Collins FM. Mycobacterium avium-complex infections and development of the acquired immunodeficiency syndrome: casual opportunist or causal cofactor? Int J Lepr Other Mycobact Dis. 1986 Sep;54(3):458–474. [PubMed] [Google Scholar]
- Draper P, Rees RJ. Electron-transparent zone of mycobacteria may be a defence mechanism. Nature. 1970 Nov 28;228(5274):860–861. [PubMed] [Google Scholar]
- Drutz DJ, Cline MJ, Levy L. Leukocyte antimicrobial function in patients with leprosy. J Clin Invest. 1974 Feb;53(2):380–386.[PMC free article] [PubMed] [Google Scholar]
- Ellner JJ, Daniel TM. Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol. 1979 Feb;35(2):250–257.[PMC free article] [PubMed] [Google Scholar]
- Gaylord H, Brennan PJ, Young DB, Buchanan TM. Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun. 1987 Nov;55(11):2860–2863.[PMC free article] [PubMed] [Google Scholar]
- Godal T, Myklestad B, Samuel DR, Myrvang B. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. Clin Exp Immunol. 1971 Dec;9(6):821–831.[PMC free article] [PubMed] [Google Scholar]
- Hard GC. Comparative toxic effect of the surface lipid of Corynebacterium ovis on peritoneal macrophages. Infect Immun. 1975 Dec;12(6):1439–1449.[PMC free article] [PubMed] [Google Scholar]
- Sibley Richard K, Olivari Maria-Teresa, Ring W Steves, Bolman R Morton. Letters to the Editor. Ann Surg. 1986 Dec;204(6):b725–726.[PMC free article][Google Scholar]
- Horwitz MA, Levis WR, Cohn ZA. Defective production of monocyte-activating cytokines in lepromatous leprosy. J Exp Med. 1984 Mar 1;159(3):666–678.[PMC free article] [PubMed] [Google Scholar]
- Hunter SW, Gaylord H, Brennan PJ. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem. 1986 Sep 15;261(26):12345–12351. [PubMed] [Google Scholar]
- Kaplan G, Gandhi RR, Weinstein DE, Levis WR, Patarroyo ME, Brennan PJ, Cohn ZA. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol. 1987 May 1;138(9):3028–3034. [PubMed] [Google Scholar]
- Kaplan G, Nathan CF, Gandhi R, Horwitz MA, Levis WR, Cohn ZA. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy. J Immunol. 1986 Aug 1;137(3):983–987. [PubMed] [Google Scholar]
- Krahenbuhl JL, Remington JS. Cytostatic effects of activated macrophages on tumor target cells: inhibition of cytotoxic action of ARA-C. J Immunopharmacol. 1980;2(3):325–348. [PubMed] [Google Scholar]
- Mackaness GB. Resistance to intracellular infection. J Infect Dis. 1971 Apr;123(4):439–445. [PubMed] [Google Scholar]
- Mehra V, Mason LH, Rothman W, Reinherz E, Schlossman SF, Bloom BR. Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. J Immunol. 1980 Sep;125(3):1183–1188. [PubMed] [Google Scholar]
- Misaki A, Azuma I, Yamamura Y. Structural and immunochemical studies on D-arabino-D-mannans and D-mannans of Mycobacterium tuberculosis and other Mycobacterium species. J Biochem. 1977 Dec;82(6):1759–1770. [PubMed] [Google Scholar]
- Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1983 Sep 1;158(3):670–689.[PMC free article] [PubMed] [Google Scholar]
- Nathan CF, Kaplan G, Levis WR, Nusrat A, Witmer MD, Sherwin SA, Job CK, Horowitz CR, Steinman RM, Cohn ZA. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med. 1986 Jul 3;315(1):6–15. [PubMed] [Google Scholar]
- Parks DR, Bryan VM, Oi VT, Herzenberg LA. Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci U S A. 1979 Apr;76(4):1962–1966.[PMC free article] [PubMed] [Google Scholar]
- Ridley DS. Histological classification and the immunological spectrum of leprosy. Bull World Health Organ. 1974;51(5):451–465.[PMC free article] [PubMed] [Google Scholar]
- Rook GA, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J, Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology. 1986 Jan;57(1):159–163.[PMC free article] [PubMed] [Google Scholar]
- Ryan JL, Gobran L, Morrison DC. Modulation of murine macrophage metabolism by glycolipids: inhibition of LPS-induced metabolism by specific gangliosides. J Leukoc Biol. 1986 Oct;40(4):367–379. [PubMed] [Google Scholar]
- Sibley LD, Franzblau SG, Krahenbuhl JL. Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages. Infect Immun. 1987 Mar;55(3):680–685.[PMC free article] [PubMed] [Google Scholar]
- Sibley LD, Krahenbuhl JL. Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon. Infect Immun. 1987 Feb;55(2):446–450.[PMC free article] [PubMed] [Google Scholar]
- Sibley LD, Krahenbuhl JL. Defective activation of granuloma macrophages from Mycobacterium leprae-infected nude mice. J Leukoc Biol. 1988 Jan;43(1):60–66. [PubMed] [Google Scholar]